Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lymphocyte Activation
100%
Programmed Death-ligand 1 (PD-L1)
100%
Spleen Lymphocytes
100%
FTI-277
100%
Farnesyltransferase Inhibitor
100%
Programmed Death-ligand 1 Expression
100%
Sepsis
57%
Cecal Puncture
42%
Cecal Ligation
42%
Farnesyltransferase
42%
Protein Expression
28%
Signaling Pathway
28%
Lymphocyte Apoptosis
28%
Lymphocytes
14%
Tumor
14%
Dose Effect
14%
Protein Level
14%
MRNA Expression
14%
Clinical Trials
14%
Interleukin-2
14%
Survival Rate
14%
Flow Cytometric Analysis
14%
Therapeutic Target
14%
Spleen
14%
Anti-inflammatory Effect
14%
Interferon-α (IFN-α)
14%
Bacterial Infection
14%
Cytokine Expression
14%
Sham Treatment
14%
Nuclear factor-κB
14%
CD28
14%
Damping Effect
14%
Overall Survival Rate
14%
Anti-inflammatory Function
14%
Splenocyte Proliferation
14%
CD3+
14%
Infection-bacterial
14%
Sepsis Treatment
14%
Programmed death-1/programmed Death-ligand 1
14%
Chronic Viral Infection
14%
Bacterial Sepsis
14%
Nuclear factor-κB Pathway
14%
Lymphocyte Activity
14%
Medicine and Dentistry
Lymphocyte Activation
100%
Spleen Lymphocyte
100%
Programmed Death 1 Ligand 1
100%
Farnesyltransferase Inhibitor
100%
Sepsis
55%
Protein Expression
22%
Puncture
22%
Survival Rate
22%
Immunoglobulin Enhancer Binding Protein
22%
Ligation
22%
Lymphocyte Apoptosis
22%
Signal Transduction
22%
Neoplasm
11%
Sham Procedure
11%
Cytokine
11%
Antiinflammatory Activity
11%
Virus Infection
11%
Secretion (Process)
11%
Bacterial Infection
11%
Overall Survival
11%
Cecal Ligation and Puncture-Induced Sepsis
11%
Mouse Study
11%
Anti-Inflammatory Drug
11%
Clinical Trial
11%
Immunosuppressive Drug
11%
Interleukin 2
11%
Interferon
11%
Messenger RNA
11%
Lymphocyte
11%
CD3 Antigen
11%
Immunology and Microbiology
Lymphocyte Activation
100%
Programmed Death 1 Ligand 1
100%
Spleen Lymphocyte
100%
Lymphocyte Apoptosis
22%
Survival Rate
22%
Protein Expression
22%
Immunoglobulin Enhancer Binding Protein
22%
Signal Transduction
22%
Splenocyte
11%
Interferon Type I
11%
Immunosuppressive Drug
11%
Viral Disease
11%
Secretion (Process)
11%
Antiinflammatory Activity
11%
CD28
11%
Interleukin 2
11%
Overall Survival
11%
Cytokine
11%
Lymphocyte
11%
Immunology
11%
CD3 Antigen
11%
Pharmacology, Toxicology and Pharmaceutical Science
Programmed Death 1 Ligand 1
100%
Protein Farnesyltransferase Inhibitor
100%
Sepsis
55%
Survival Rate
22%
Immunoglobulin Enhancer Binding Protein
22%
Clinical Trial
11%
Placebo
11%
Anti-Inflammatory Drug
11%
Antiinflammatory Activity
11%
Immunosuppressive Agent
11%
Cytokine
11%
Bacterial Infection
11%
Virus Infection
11%
Cecal Ligation and Puncture-Induced Sepsis
11%
Overall Survival
11%
Neoplasm
11%
Interleukin 2
11%
Interferon
11%
Messenger RNA
11%
CD3 Antigen
11%